jurgenfrInsmed (NASDAQ:INSM) reported preliminary 2024 revenue results for its drug Arikayce and issued 2025 revenue guidance. The drugmaker said 2024…
Brett_Hondow/iStock Editorial via Getty ImagesLennar (NYSE:LEN) shares slid 7.8% in Wednesday after-hours trading after the homebuilder turned in Q4 earnings…